Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06859281 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety, Tolerability, and Pharmacokinetic Profile of Grammidin, a Metered Dose Topical Spray in Healthy Volunteers

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Interventions: Grammidin neo (Drug), Grammidin, a metered spray for local application (Drug) to Grammidin neo (Drug), Grammidin, a metered dose topical spray (Drug)
    • Eligibility criteria shortened, about 5 words
    • Study title expanded, about 2 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the safety, tolerability, and pharmacokinetic profile of the Grammidin, a metered dose topical spray, compared to Grammidin lozenges following single administration in healthy volunteers .
Trial Details
NCT Number NCT06859281
Lead Sponsor Valenta Pharm JSC
Conditions
(from sponsor)		 Pharyngitis
Related terms Pharyngitis
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov